Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

Proof-of-Concept Case-Control Study for Hepatocellular Carcinoma Identification Using Delta-HLD Technology (HIDE)

OBSERVATIONALInicio: 18 de may de 2023ID: NCT07148310

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Rademikibart as an Add-on Treatment for Acute Exacerbation in Participants With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

INTERVENTIONALInicio: 12 de ago de 2025ID: NCT06940154

ReclutandoClinicalTrials.gov

Careful Ventilation in Acute Respiratory Distress Syndrome

INTERVENTIONALInicio: 23 de nov de 2020ID: NCT03963622

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL)

INTERVENTIONALInicio: 8 de may de 2025ID: NCT06935357

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose Range-finding, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ALXN2420, a Growth Hormone Receptor Antagonist, Administered Subcutaneously in Combination With Somatostatin Analogs in Adult Participants With Acromegaly

INTERVENTIONALInicio: 28 de oct de 2025ID: NCT07037420

ReclutandoFase 3ClinicalTrials.gov

A Phase 2/3 Multicenter, Open-label, Randomized, Active-Control Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (waveLINE-003)

INTERVENTIONALInicio: 14 de ene de 2022ID: NCT05139017

ReclutandoClinicalTrials.gov

Pilot Test for an Early Diagnosis Kit for Breast Cancer Based on Liquid Biopsies

OBSERVATIONALInicio: 14 de jul de 2021ID: NCT06439940

ReclutandoFase 2ClinicalTrials.gov

A Phase 1/2 Open-label, Multicentre, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, and Clinical Activity of Belantamab as Monotherapy and in Combination With Other Treatments in Participants With Multiple Myeloma

INTERVENTIONALInicio: 14 de jun de 2023ID: NCT05714839

ReclutandoFase 1ClinicalTrials.gov

A Phase I, 2-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-ascending Doses of Intrathecally Administered RG6496 in a Randomized, Placebo-controlled, Investigator/Participant-blind Study With an Open-label Extension in Huntington's Disease Gene Expansion Carriers

INTERVENTIONALInicio: 19 de nov de 2025ID: NCT07246941

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression

INTERVENTIONALInicio: 2 de dic de 2024ID: NCT06667700

ReclutandoFase 4ClinicalTrials.gov

An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments

INTERVENTIONALInicio: 27 de ago de 2024ID: NCT06337032

ReclutandoClinicalTrials.gov

Pompe Disease Registry

OBSERVATIONALInicio: 15 de sept de 2004ID: NCT00231400

ReclutandoClinicalTrials.gov

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

OBSERVATIONALInicio: 1 de mar de 2001ID: NCT02832245

ReclutandoClinicalTrials.gov

Exploration of Neurophysiological Mechanisms of Exercise-Induced Hypoalgesia With Blood Flow Restriction in Healthy Adults

INTERVENTIONALInicio: 4 de ago de 2025ID: NCT07122011

ReclutandoFase 1ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for the Treatment of Stroke

INTERVENTIONALInicio: 1 de feb de 2022ID: NCT05158101

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Dulaglutide 3.0 mg and 4.5 mg in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus

INTERVENTIONALInicio: 10 de ene de 2025ID: NCT06739122

ReclutandoFase 3ClinicalTrials.gov

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease

INTERVENTIONALInicio: 22 de nov de 2024ID: NCT05552157

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung02)

INTERVENTIONALInicio: 18 de nov de 2024ID: NCT06692738

ReclutandoFase 3ClinicalTrials.gov

A Phase 2/3, Multicenter, Double-Blind, Randomized Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic or Non-Neuronopathic Mucopolysaccharidosis Type II

INTERVENTIONALInicio: 21 de jul de 2022ID: NCT05371613

ReclutandoClinicalTrials.gov

A Multi-national Real-world Outcomes and Treatment Patterns Study of Lanadelumab (Takhzyro) in Paediatric Patients With Hereditary Angioedema (TAHORA)

OBSERVATIONALInicio: 5 de feb de 2026ID: NCT07251933